Chesley Taft & Associates LLC Amgen Inc Transaction History

Chesley Taft & Associates LLC

$2.08 Billion
Q3 2024

A detailed history of Chesley Taft & Associates LLC transactions in Amgen Inc stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 18,922 shares of AMGN stock, worth $5.49 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

18,922

Previous 18,748 0.93%

Holding current value

$5.49 Million

Previous $5.86 Million 4.08%

% of portfolio

0.29%

Previous 0.3%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$309.38 - $337.38 $53,832 - $58,704	174 Added 0.93%	18,922 $6.1 Million
Q2 2024 Jul 19, 2024	SELL	$262.75 - $319.31 $57,016 - $69,290	-217 Reduced 1.14%	18,748 $5.86 Million
Q1 2024 Apr 15, 2024	BUY	$268.87 - $324.56 $157,557 - $190,192	586 Added 3.19%	18,965 $5.39 Million
Q4 2023 Jan 11, 2024	BUY	$255.7 - $288.46 $357,724 - $403,555	1,399 Added 8.24%	18,379 $5.29 Million
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $669,069 - $830,667	3,060 Added 21.98%	16,980 $4.56 Million
Q1 2023 Apr 11, 2023	SELL	$225.79 - $275.2 $10,160 - $12,384	-45 Reduced 0.32%	13,920 $3.37 Million
Q4 2022 Jan 19, 2023	SELL	$229.03 - $291.01 $6,870 - $8,730	-30 Reduced 0.21%	13,965 $0
Q3 2022 Oct 13, 2022	SELL	$224.46 - $253.15 $29,179 - $32,909	-130 Reduced 0.92%	13,995 $3.15 Million
Q2 2022 Jul 07, 2022	SELL	$230.71 - $256.74 $4,614 - $5,134	-20 Reduced 0.14%	14,125 $3.44 Million
Q1 2022 Apr 14, 2022	BUY	$219.27 - $242.57 $16,445 - $18,192	75 Added 0.53%	14,145 $3.54 Million
Q4 2021 Jan 05, 2022	BUY	$198.88 - $227.6 $213,796 - $244,670	1,075 Added 8.27%	14,070 $3.17 Million
Q3 2021 Oct 05, 2021	SELL	$212.27 - $248.7 $1,061 - $1,243	-5 Reduced 0.04%	12,995 $2.76 Million
Q2 2021 Jul 07, 2021	SELL	$233.58 - $259.14 $10.7 Million - $11.9 Million	-45,729 Reduced 77.86%	13,000 $3.17 Million
Q1 2021 Apr 06, 2021	BUY	$221.91 - $258.6 $16,643 - $19,395	75 Added 0.13%	58,729 $14.8 Million
Q4 2020 Jan 11, 2021	BUY	$216.38 - $257.67 $9.77 Million - $11.6 Million	45,156 Added 334.54%	58,654 $13.5 Million
Q3 2020 Oct 08, 2020	SELL	$234.65 - $260.95 $32,851 - $36,533	-140 Reduced 1.03%	13,498 $3.43 Million
Q2 2020 Jul 08, 2020	SELL	$197.81 - $242.74 $50,441 - $61,898	-255 Reduced 1.84%	13,638 $3.22 Million
Q1 2020 Apr 15, 2020	BUY	$182.24 - $241.7 $417,329 - $553,493	2,290 Added 19.74%	13,893 $2.82 Million
Q4 2019 Jan 10, 2020	SELL	$189.21 - $243.2 $3,784 - $4,864	-20 Reduced 0.17%	11,603 $2.8 Million
Q3 2019 Oct 07, 2019	SELL	$174.11 - $208.62 $700,618 - $839,486	-4,024 Reduced 25.72%	11,623 $2.25 Million
Q2 2019 Jul 10, 2019	BUY	$166.7 - $195.41 $57,511 - $67,416	345 Added 2.25%	15,647 $2.88 Million
Q1 2019 Apr 05, 2019	SELL	$180.87 - $203.88 $1.3 Million - $1.47 Million	-7,202 Reduced 32.0%	15,302 $2.91 Million
Q4 2018 Jan 07, 2019	SELL	$178.4 - $208.25 $90,984 - $106,207	-510 Reduced 2.22%	22,504 $4.38 Million
Q3 2018 Oct 12, 2018	BUY	$185.29 - $208.89 $180,657 - $203,667	975 Added 4.42%	23,014 $4.77 Million
Q2 2018 Jul 12, 2018	SELL	$166.05 - $186.51 $98,135 - $110,227	-591 Reduced 2.61%	22,039 $4.07 Million
Q1 2018 Apr 11, 2018	BUY	$169.43 - $198.0 $277,865 - $324,720	1,640 Added 7.81%	22,630 $3.86 Million
Q4 2017 Jan 10, 2018	BUY	$168.79 - $188.59 $1.96 Million - $2.19 Million	11,603 Added 123.61%	20,990 $3.65 Million
Q3 2017 Oct 13, 2017	BUY	$167.29 - $191.0 $1.57 Million - $1.79 Million	9,387	9,387 $1.75 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesley Taft & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesley Taft & Associates LLC with notifications on news.

Account

Chesley Taft & Associates LLC Amgen Inc Transaction History